Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Antiemetics And Antinauseants Market Growth in 2025?

The market for antiemetics and antinauseants has seen a consistent expansion in the past few years. It is projected to rise from $8.11 billion in 2024 to $8.45 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.3%. Factors contributing to this growth in the previous era include legacy branding and market rivalry, traditional treatment choices, economic circumstances, past global health incidents, along with medical advancements and research.

What Is the Forecast for the Antiemetics And Antinauseants Market Size Through 2029?

The market for antiemetics and antinauseants is projected to experience a stable growth pattern in the coming years, with its value anticipated to reach $9.7 billion by 2029, expanding at a compound annual growth rate (CAGR) of 3.5%. This growth over the forecast period is largely due to factors such as research, development activities, economic conditions, market rivalry, industry trends, evolving disease profiles, and healthcare policies and regulations. Key trends anticipated during the forecast period involve a heightened emphasis on the experience of patients, changes in healthcare regulations, a patient inclination towards non-invasive treatments, a rising occurrence of nausea related to chemotherapy and pregnancy, and the introduction of targeted therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What are the Key Market Players in Antiemetics And Antinauseants Market and How They’re Evolving?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

What Are the Primary Growth Drivers in the Antiemetics And Antinauseants Market?

The market for antiemetics and antinauseants is fuelled by the growing prevalence of cancer. As one of the top suggested solutions for cancer, chemotherapy often results in side effects like chemotherapy-induced nausea and vomiting (CINV), which can be averted in about 60%-70% of patients using antiemetics. For example, in April 2024, The American Cancer Society, a US-based non-profit organization, estimated approximately 609,000 cancer-related fatalities and an expected 1.9 million new cases of cancer in the US in 2022. An approximated 620,000 cancer-associated deaths are projected, indicating a slight rise in death rates in 2024. As cancer incidence rates continue to rise, so will the need for antiemetics and antinauseants, thereby fueling the market’s revenue stream.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

What Are the Leading Segments in the Global Antiemetics And Antinauseants Industry?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Are the Key Market Trends in the Antiemetics And Antinauseants Industry?

Prominent entities within the antiemetic and antinauseant markets are focusing on introducing novel products such as ready-for-use injectables to simplify treatment procedures and improve patient adherence. These ready-for-use solutions aim to offer immediate relief, thereby curbing the time and complexities often tied with traditional injectable medications. For instance, Amneal Pharmaceuticals, a specialty pharmaceutical company based in the US, in July 2024, debuted FOCINVEZ, which is the first ready-to-use injectable fosaprepitant formulation, purposed for preventing acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. The product comes in a 150 mg/50 mL bottle format, sans Polysorbate 80, and eliminates the need for reconstitution or dilution, thereby enabling straightforward administration. FOCINVEZ, approved for adults and pediatric patients as young as six months, has been given a distinct J-Code (J1434) for reimbursement purposes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Is the Regional Outlook for the Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

This Report Delivers Insight On:

1. How big is the antiemetics and antinauseants market, and how is it changing globally?

2. Who are the major companies in the antiemetics and antinauseants market, and how are they performing?

3. What are the key opportunities and risks in the antiemetics and antinauseants market right now?

4. Which products or customer segments are growing the most in the antiemetics and antinauseants market?

5. What factors are helping or slowing down the growth of the antiemetics and antinauseants market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model